It's not only the company's record profit that investors are celebrating.

This semiconductor stock continues to crush the major indexes for all the right reasons.

Biogen has had an impressive run over the past six months as its shares have beaten the S&P 500 by 19.7%. The stock now trades at $183.50, marking a 25.5% gain. This was partly due to its solid quarterly results, and the performance may have investors won

The president said he expected the S&P 500 and the Dow to fall 20% and oil to hit $200 a barrel due to the war with Iran

Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at Qualys (NASDAQ:QLYS) and its peers.

The WisdomTree Japan Hedged Equity Fund is an effective tool for investors looking to follow Berkshire Hathaway into Japan.

This science and engineering consulting firm reported a notable insider sale as shares posted a double-digit decline over the past year.

Blue-chip retailers will see the biggest tariff refunds.

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at DaVita (NYSE:DVA) and the best and worst performers in the outpatient & specialty care industry.

(Bloomberg) -- Prediction markets are pouring money into Washington to defend against escalating criticism that their fast-growing platforms are contributing to a gambling explosion and enabling insider trading. Most Read from BloombergKuwait Declares Fur

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Granite Construction (NYSE:GVA) and the best and worst performers in the construction and maintena

Setting up an automatic dividend reinvestment could generate monster total returns from these dividend stocks in the coming decade.

The stocks featured in this article are seeing some big returns. Over the past month, they’ve outpaced the market due to some combination of positive news, upbeat results, or supportive macro developments. As such, investors are taking notice and bidding

Can Eli Lilly cure cancer? Maybe -- with a little help.

Large-cap stocks are known for their staying power and ability to weather market storms better than smaller competitors. However, their sheer size makes it more challenging to maintain high growth rates as they’ve already captured significant portions of